Twilio (TWLO) will replace Amedisys(AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group (UNH) acquired Amedisys in a deal completed August 14.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TWLO:
- Twilio’s Strategic Positioning and AI Advancements Signal Strong Buy Opportunity
- Twilio’s Earnings Call: Growth Amid Challenges
- Twilio’s Strong Financial Performance and Strategic Initiatives Drive Buy Recommendation
- Twilio’s Stock Plunge: A Buying Opportunity?
- Is Twilio Stock (TWLO) a Buy After Its Q2 Earnings Dip?